Allworth Financial’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.7K Buy
818
+140
+21% +$10.1K ﹤0.01% 2240
2026
Q1
$46.2K Buy
678
+44
+7% +$3.12K ﹤0.01% 2379
2025
Q4
$48.2K Buy
634
+247
+64% +$18K ﹤0.01% 2225
2025
Q3
$23.8K Buy
387
+73
+23% +$3.8K ﹤0.01% 2592
2025
Q2
$15.3K Buy
314
+245
+355% +$11.6K ﹤0.01% 2679
2025
Q1
$3.42K Hold
69
– – ﹤0.01% 2970
2024
Q4
$3.11K Hold
69
– – ﹤0.01% 2976
2024
Q3
$2.56K Sell
69
-21
-23% -$703 ﹤0.01% 2855
2024
Q2
$2.94K Hold
90
– – ﹤0.01% 2756
2024
Q1
$2.62K Hold
90
– – ﹤0.01% 2711
2023
Q4
$2.48K Buy
+90
New +$2.06K ﹤0.01% 2583
2023
Q3
– Sell
-28
Closed -$1.14K – 3529
2023
Q2
$1.14K Sell
28
-20
-42% -$979 ﹤0.01% 2692
2023
Q1
$2.33K Buy
48
+20
+71% +$914 ﹤0.01% 2349
2022
Q4
$1.07K Sell
28
-1
-3% -$42 ﹤0.01% 2449
2022
Q3
$1K Buy
+29
New +$1.42K ﹤0.01% 2471
2022
Q1
– Sell
-9
Closed – – 2322
2021
Q4
$0 Sell
9
-273
-97% -$10.4K ﹤0.01% 2083
2021
Q3
$10K Buy
+282
New +$11.6K ﹤0.01% 1343
2016
Q4
– Sell
-900
Closed -$13K – 723
2016
Q3
$13K Hold
900
– – ﹤0.01% 384
2016
Q2
$6K Buy
+900
New +$6.6K ﹤0.01% 437

Other funds holding PTCT

Allworth Financial's PTCT Position: Q2 2026 in Review

Allworth Financial increased its PTC Therapeutics (PTCT) stake by 21% in Q2 2026, buying an estimated $10.1K and bringing the position to 818 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Allworth Financial first reported a position in PTCT in Q2 2016 and has held it in 19 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Allworth Financial held 818 shares of PTC Therapeutics worth $66.7K as of Q2 2026.
  • Allworth Financial bought 140 PTC Therapeutics shares in Q2 2026, an estimated $10.1K.
  • PTC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2240 holding.
  • Allworth Financial first reported a position in PTC Therapeutics in Q2 2016 and has held it in 19 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.